Gritstone Bio Inc

NASDAQ:GRTS  
7.59
-0.12 (-1.56%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)373.40M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$2.24 Million
Adjusted EPS-$0.58
See more estimates
10-Day MA$7.94
50-Day MA$9.00
200-Day MA$8.68
See more pivots

Gritstone Bio Inc Stock, NASDAQ:GRTS

5959 Horton Street, Suite 300, Emeryville, California 94608
United States of America
Phone: +1.510.871.6100
Number of Employees: 169

Description

Gritstone bio, Inc. clinical-stage biotechnology company, which engages in developing the next generation of cancer immunotherapies to fight multiple cancer types. The company was founded by Andrew Allen, Timothy Chan, Mark Cobbold, Graham Lord, Naiyer Rizvi and Jean-Charles Soria in August 2015 and is headquartered in Emeryville, CA.